Lesion Localization in Patients With a Previous Negative Transrectal Ultrasound Biopsy and Persistently Elevated Prostate Specific Antigen Level Using Diffusion-Weighted Imaging at Three Tesla Before Rebiopsy
- 1 November 2008
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Investigative Radiology
- Vol. 43 (11), 789-793
- https://doi.org/10.1097/rli.0b013e318183725e
Abstract
To assess the use of diffusion-weighted imaging (DWI) at 3 Tesla (T) for lesion localization in patients with a high risk of prostate cancer before a rebiopsy. A total of 43 patients (age range, 40–80 years; mean age, 62.6 years) who had previously undergone a transrectal ultrasound (TRUS)-guided biopsy that was negative and continued to have a persistent elevated prostate specific antigen level underwent DWI with b = 0 s/mm2 and b = 1000 s/mm2 before a rebiopsy. We located the area of the lowest apparent diffusion coefficient values and performed a target biopsy of that area, followed by a systematic biopsy under TRUS guidance. We evaluated the cancer detection rate, tumor location, and lesion visibility on T2-weighted imaging (T2WI) in patients with biopsy-proven cancers. Prostate cancer was detected in 17 (39.5%) patients, and was more predominant in the transitional zone (76.4%, 13/17) than in the peripheral zone (23.6%, 4/17) (P Conclusion: DWI in addition to T2WI at 3 T has the potential to provide important information on lesion localization in patients that had both previous negative TRUS biopsy and persistently elevated prostate specific antigen levels before a repeated biopsy.Keywords
This publication has 18 references indexed in Scilit:
- Combined T2-Weighted and Diffusion-Weighted MRI for Localization of Prostate CancerAmerican Journal of Roentgenology, 2007
- Diffusion Tensor Magnetic Resonance Imaging of Prostate CancerInvestigative Radiology, 2007
- Diffusion-Weighted Imaging of the Prostate at 3 T for Differentiation of Malignant and Benign Tissue in Transition and Peripheral ZonesJournal of Computer Assisted Tomography, 2007
- Prostate cancer screening: The clinical value of diffusion‐weighted imaging and dynamic MR imaging in combination with T2‐weighted imagingJournal of Magnetic Resonance Imaging, 2006
- Diffusion‐weighted imaging of normal and malignant prostate tissue at 3.0TJournal of Magnetic Resonance Imaging, 2005
- Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostateJournal of Magnetic Resonance Imaging, 2005
- Whole-body MRI at high field: technical limits and clinical potentialEuropean Radiology, 2005
- Endorectal diffusion‐weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissueJournal of Magnetic Resonance Imaging, 2004
- MR imaging of the prostate at 3 teslaAcademic Radiology, 2004
- High field body MR imaging: Preliminary experiencesClinical Imaging, 2004